Hangzhou Aichek Medical Technology Co.,Ltd
| Payment Terms | T/T |
| Supply Ability | negotiable |
| Packaging Details | 40box/carton |
| Storage | 2℃-30℃ |
| Sample Type | Swab |
| User | Professional |
| Accuracy | 99.6% (97.7%-99.9%) |
| Certificate | CE ISO 13485 |
| OEM | OEM customized packing avaliable |
| Formats | 25T/box 1T/box |
| After-sales Service | Available |
| Key words | Influenza A+B Antigen Rapid Test |
| For the crowd | Preliminary screening of infected people |
| Brand Name | Aichek |
| Model Number | CHL-A01 |
| Certification | CE |
| Place of Origin | China |
View Detail Information
Explore similar products
25 Strips Chlamydia Rapid Test Kit 97.7% Adenovirus Ag Rapid Test
1 Piece Typhidot Igm Test Infectious Disease Rapid Test Kits
Urine Strep A Rapid Test Kit 99.9% Accuracy Adenovirus Rapid Test
Swab 97.7% Influenza AB Test Infectious Disease Rapid Test Kits
Product Specification
| Payment Terms | T/T | Supply Ability | negotiable |
| Packaging Details | 40box/carton | Storage | 2℃-30℃ |
| Sample Type | Swab | User | Professional |
| Accuracy | 99.6% (97.7%-99.9%) | Certificate | CE ISO 13485 |
| OEM | OEM customized packing avaliable | Formats | 25T/box 1T/box |
| After-sales Service | Available | Key words | Influenza A+B Antigen Rapid Test |
| For the crowd | Preliminary screening of infected people | Brand Name | Aichek |
| Model Number | CHL-A01 | Certification | CE |
| Place of Origin | China | ||
| High Light | 99.6% Influenza AB Rapid Test ，99.6% Infectious Disease Rapid Test Kits ，influenza ab test kit | ||
| Product Name | Influenza A+B Antigen Rapid Test |
| Formats | Strip(3mm)Device(4mm) |
| Place of Origen | China |
| Specimen | swab |
| Read Time | 15 minutes |
| Shelf life | 2 years |
| Package | 25 device/box or 50 strip/Box |
| Storage | 2℃-30℃ |
For professional in vitro diagnostic use only
The Influenza A+B Rapid Test Device is a rapid chromatographic immunoassay for the qualitative detection of influenza A and B antigens in nasal swab or throat swab or nasal aspirate specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.
The Influenza A+B Rapid Test Device (Swab/Nasal Aspirate) has been evaluated with specimens obtained from the patients. RT-PCR is used as the reference method for the Influenza A+B Rapid Test Device (Swab/Nasal Aspirate). Specimens were considered positive if RT-PCR indicated a positive result. Specimens were considered negative if RT-PCR indicated a negative result Nasal Swab Specimen.
Nasal Swab Specimen
| Type A | Type B | ||||||
| RT-PCR | Total | RT-PCR | Total | ||||
| Positive | Negative | Positive | Negative | ||||
Flu A+B Rapid Test Strip | Positive | 100 | 2 | 102 | 85 | 2 | 87 |
| Negative | 1 | 180 | 181 | 2 | 200 | 202 | |
| Total | 101 | 182 | 283 | 87 | 202 | 289 | |
| Relative Sensitivity | 99.0% | 97.7% | |||||
| Relative Specificity | 98.9% | 99.0% | |||||
| Accuracy | 98.9% | 98.6% | |||||
Throat Swab Specimen
| Type A | Type B | ||||||
| RT-PCR | Total | RT-PCR | Total | ||||
| Positive | Negative | Positive | Negative | ||||
Flu A+B Rapid Test Device | Positive | 58 | 1 | 59 | 65 | 1 | 66 |
| Negative | 3 | 150 | 153 | 4 | 162 | 166 | |
| Total | 61 | 151 | 212 | 69 | 163 | 232 | |
| Relative Sensitivity | 95.1% | 94.2% | |||||
| Relative Specificity | 99.3% | 99.4% | |||||
| Accuracy | 98.1% | 97.8% | |||||
Nasal Aspirate Specimen
| Type A | Type B | ||||||
| RT-PCR | Total | RT-PCR | Total | ||||
| Positive | Negative | Positive | Negative | ||||
Flu A+B Rapid Test Device | Positive | 46 | 2 | 48 | 94 | 1 | 95 |
| Negative | 0 | 241 | 241 | 2 | 158 | 160 | |
| Total tal tal | 46 | 243 | 289 | 96 | 159 | 255 | |
| Relative Sensitivity | 100% | 97.9% | |||||
| Relative Specificity | 99.2% | 99.4% | |||||
| Accuracy | 99.3% | 98.8% | |||||
Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract .It is a communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus. 1 Influenza outbreaks occur each year during the fall and winter months. Type A viruses are typically more prevalent than type B viruses and are associated with most serious influenza epidemics, while type B infections are usually milder. The gold standard of laboratory diagnosis is 14-day cell culture with one of a variety of cell lines that can support the growth of influenza virus. 2 Cell culture has limited clinical utility, as results are obtained too late in the clinical course for effective patient intervention. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a newer method that is generally more sensitive than culture with improved detection rates over culture of 2-23%.3 However, RT-PCR is expensive, complex and must be performed in specialized laboratories. The Influenza A+B Rapid Test Device (Swab/Nasal Aspirate) qualitatively detects the presence of Influenza A and/or Influenza B antigen in nasal swab or throat swab or nasal aspirate specimens ,providing results within 15 minutes. The test uses antibodies specific for Influenza A and Influenza B to selectively detect Influenza A and Influenza B antigen in nasal swab, throat swab or nasal aspirate specimens.
Company Details
Business Type:
Manufacturer
Year Established:
2012
Total Annual:
500000-1000000
Employee Number:
150~200
Ecer Certification：
Active Member
Hangzhou Aichek Medical Technology Co.,Ltd Hangzhou Aichek Medical Technology Co.,Ltd is a high-tech company specialises in manufacturing rapid diagnostic and healthcare products. With five product lines of fertility, infectious diseases, cardiac marker, tumor marker and drug of... Hangzhou Aichek Medical Technology Co.,Ltd Hangzhou Aichek Medical Technology Co.,Ltd is a high-tech company specialises in manufacturing rapid diagnostic and healthcare products. With five product lines of fertility, infectious diseases, cardiac marker, tumor marker and drug of...
Get in touch with us
Leave a Message, we will call you back quickly!